ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DOX vs EPAM // REVENUE GROWTH (YOY)

Amdocs Limited (NASDAQ) VS. EPAM Systems Inc. (NYSE) • 15-METRIC TALLY: DOX 9 — EPAM 4
▲ REVENUE GROWTH (YOY) LEADER: EPAM
revenue-growth
2.40%
revenue-growth
15.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DOX VS. EPAM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DOX EPAM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 35.10% 28.80% +6.30 DOX /gross-margins <GO>
Return on Invested Capital (ROIC) 23.60% 17.10% +6.50 DOX /roic <GO>
EV/EBITDA & P/E Valuation 9.7x 10.2x -0.50 DOX /valuation <GO>
Free Cash Flow Yield 9.21% 8.82% +0.39 DOX /fcf-yield <GO>
Operating Margin 12.60% 9.50% +3.10 DOX /operating-margins <GO>
Net Profit Margin 9.90% 6.90% +3.00 DOX /net-margins <GO>
Revenue Growth (YoY) ACTIVE 2.40% 15.40% -13.00 EPAM /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 3.16% 0.00% +3.16 DOX /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.98 5.67 -0.69 EPAM /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 58.0 61.4 -3.40 EPAM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.39 1.37 +0.02 DOX /macro-sensitivity <GO>
Forward P/E Multiple 12.6x 15.5x -2.90 DOX /forward-pe <GO>
Enterprise Scale & Market Cap $6.72B $6.95B -$232.1M EPAM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DOX REV EPAM REV DOX GROSS % EPAM GROSS % DOX FCF EPAM FCF
FY 2025 — $5.46B — 28.8% — $612.7M
FY 2024 $5.00B $4.73B 35.1% 30.7% $618.9M $527.0M
FY 2023 $4.89B $4.69B — — $602.7M $351.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DOX // BETA 1.39
EPAM // BETA 1.37